Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I love Nader. On the proactive he says they want CYDY to be Gilead x 100. Wow! Come on everyone all you have to do is get him his 200 million shares and he's going to make it happen. Is there anything this guy won't do or say?
He said:
1. I worked for free for the first year.
2. I want to buy, but every time I try legal says I can't.
Maybe the next time Mulholland goes to sell his shares on the open market, he can remind Nader to buy.
He did go 1 year without getting paid. He wants to buy, it's just every time he remembers to buy, legal says he can't. Oh well...
I post this with as much respect as I possibly can and then I'm taking a break from CYDY-land for a few weeks because I just can't take it anymore. When it comes to Nader's army of blind-loyalists, so many have totally lost their minds.
People say that some day they will write a book about CYDY and all that happened. I believe that book will likely be a psychology textbook and will be studied in universities across the country.
I feel like we are living in a land under the control of cunning dictator. Who uses the power of hope, deception and fear to control the masses. I'm truly stunned at how so many under his power can so easily disregard logic and reason.
The "investor group" announced that the SEC approved their proxy statement. Explain the issue there?
1. Even If I agreed with the contentions of the press release, which I most certainly do not, it is a totally unprofessional PR. No investor relations professional would ever sign off on this. It's as if Nader just wrote it himself in a fit of rage and sent it off.
2. The contentions are themselves embarrassing and misleading. "Dark pools", "Shadow campaigns". The guy has flat lost his mind.
Wow, that is the press release of a very sick and twisted mind. If anyone thinks a management team that could issue this press releasee will ever lead us to an approval or financial success, they have lost their mind.
I actually feel bad for Nader at this point. I feel bad for all of us.
I basically read those Insider Financial articles as if NP wrote them himself. If you go back and read the outrageous claims in these Insider Financial articles that turned out to be false over the last 12 months, it really is stunning. These types of articles have been essential to NP's three-finger promotional strategy.
So fundraising has been what he's delivered? He's done two things:
1) Had Pauslon sell shares with warrants. Those were pretty sweet deals. Investors would immediately sell the shares for a quick profit and hold the free warrants. Those were very attractive deals. I don't have a problem with them, but it didn't require any special genius.
2)Fife loan deals. Are we praising the deals with Fife now? So NP released press releases that he was raising money at $10 per share. Is that what happened? These deals are a nightmare...
Everyone was screaming at the time that it made much more sense to issue new shares and raise significant money at $4-$6 per share instead of doing the awful Fife loans, but NP wanted to go the "non-dilutive" route. How did that work out?
I personally believe that NP was betting he would get EUA for Covid and could quickly pay Fife back. He bet wrong, we are now issuing Fife millions of shares for less than $2. Those shares are an obvious drag on the share price.
NP also had the benefit of the Covid bounce in the stock price which drove lots of warrant exercises, again it didn't take any special skills to make that happen.
Look, these are tough decisions and a company like Cytodyn has and had limited options in the past, but I'm not going to give Nader any special credit for doing deals with Paulson or Fife.
So I'm still waiting to hear when NP actually delivered something.
Evil Rabbit,
I sure hope NP delivers something prior to the vote. That would be great for everyone.
A serious question for you. Can you give me an example of when NP delivered something?
C20,
Only the board of directors can oust Nader and currently Nader controls the board of directors. The only way to gain control of the board of directors is to propose an alternative slate of new directors in a proxy vote. Putting together a proxy challenge such as this one is very expensive, challenging, and emotionally draining for those involved. The shareholders leading this effort have undertaken this challenge because they have tremendous belief in the potential of Leronlimab and want to see the best outcomes for investors and patients. Believe me, all the 13D members that I know have struggled through this investment like many of you. They know this company very well and are trying to bring the professional, honest and competent leadership our molecule deserves.
Kelly and NP are the only two directors who are active in day to day operations. The 3 other directors likely have very limited rolls as Kelly and NP are calling all the shots. Those are the two that I believe must be replaced. I personally see an upgrade across the board. The new board will lead an effort to find a qualified CEO that can lead the existing CYDY leadership team towards approval. This is not starting from scratch.
1. The majority of these nominated directors have been involved with CYDY for years. They don't have to learn about where CYDY has come from. They are ready to roll. Additionally, these directors will likely retain the majority of CYDY's key employees. They will provide direction, expertise, and accountability. That is the role of competent directors.
2. Current management has been telling us we are "close" for years now. I know many investors who support this effort who have been hopeful that current management would get us across the finish line but it just hasn't happened. If you believe that this time is different and that CYDY will successfully file the BLA this fall or achieve some other milestone than I can understand the desire to maintain the current management team. I and many others don't believe it will happen. I see no evidence that this time it's different. We've been sold that story one too many times.
Nobody is starting from scratch.
1. My guess is that everyone except for Kelly & NP have a great chance of being retained and those two will probably have the chance to sign some kind of consulting agreement and will have an interest in protecting the shares they have been awarded through the years.
2. Paul Rosenbaum has been a shareholder and involved with CYDY for a very long time.
3. Bruce Patterson is not starting from scratch and probably knows more about the molecule than anyone at CYDY and it isn't even close.
4. Melissa A. Yaeger is being relied on to provide expertise with the approval process which CYDY desperately needs. I believe Errico has been a shareholder for a while.
This isn't about starting from scratch. This is about upgrading CEO leadership and creating a board of directors that can provide the necessary accountability and expertise to help move Leronlimab towards approval.
I haven't been around CYDY and this board as long as many, but have enjoyed my time here over the last 18 months. As we prepare for what could be a very important day in the history of CYDY tomorrow, I wanted to share some thoughts that have been bouncing around my head about tomorrow's meeting.
1. There will be some kind of signficant news at tomorrow's meeting. It seems there is significant support on this board and others for the idea that CYDY announced a call with the Nader, Dr. Kelly, Dr. Lalezari to tell us "we will hear more in just a few days or weeks." That seems very unlikely. Nader has done things in the past that have defied explanation but I don't think that will happen this time. There were many that felt we wouldn't get a safety look into CD12 or get more analysis of CD10 until August. Nader had a little more time if he needed it, but he called this meeting and I believe he called it because they have something to share. (Could be good, could be bad)
2. Are they going to share bad news about how Leronlimab performed in these trials? Here is what I know. Nader drives me crazy. Nader may be in over his head as CEO of a $3 Billion biotech BUT, Leronlimab has not disappointed us yet. It is a jewel. In all the thousands of attacks on CYDY, on Nader, I have yet to read anything or see any evidence that states that Leronlimab is anything less than an amazing treasure of science. Sure some "hard-working" shorts say "it doesn't work" or it's a fraud but I've yet to read a single sincere post that has successfully questioned the science. Not a single one. So I believe we are going to get data tomorrow and it won't be time for Nader to speak(although he will) but the main speaker tomorrow is Leronlimab and Leronlimab has yet to disappoint us.
3. There will not be a PR of data prior to the call. If the data is what I think it is, Nader is going to want to enjoy his home run trot. We all know the setup speech we are going to hear tomorrow prior to the data. I hate it. Makes me uncomfortable. But when Nader turns the mic over to Leronlimab that is when the real talking begins.
Just a few more hours to place your bet. As for me, I will continue to place my money on Leronlimab.
Agreed Saltz. That was a fantastic, professional call. This is the real deal and we are in great position. The rewards for years of hardwork and patience are about to be realized.
I wasn't really counting on any value from Corinavirus treatment but I think we are a real factor in that conversation. Truly amazing.
Don't want to pour any cold water on this, but did we really do a deal with Martin Shkreli. This is a pretty tough pill to swallow. https://www.cnbc.com/2019/04/24/pharma-bro-martin-shkreli-moved-from-prison-after-rule-breaking.html
Another in-depth article: https://www.wsj.com/articles/martin-shkreli-steers-his-company-from-prisonwith-contraband-cellphone-11551973574
Watching the video, it seemed to me that he pretty clearly stated, we raised $10 million from TO and we hope to raise $30-$40 million. How? I have no idea. I would be stunned if they announced in a few days that they raised more than $10 million. Only way for me to explain $30-$40 million expectation would be that they will extend for long period or he is saying he expects to raise $30-$40 million from warrants at some point in the future.
I'm very bullish on CYDY and this doesn't change much for me, but NP was pretty frustrating in this video. Complete waste of time and money with this video. It raised more doubts and questions than it answered. Really frustrating...
Thank goodness our science behind Leronlimab is so strong.
Here is my favorite datapoint for just how under the radar CYDY is:
Do a google search for CCR5 Inhibitor or Antagonist or CCR5 Inhibitior drugs and try to find a mention of Leronlimab. I think there is only one page that mentions it. If you visit the Wikipedia page for CCR5 receptor antagonist, there is no mention of Leronlimab. It is just amazing.
Thanks for doing your part. I've done the same but with all the available shares on the market it is hard for retail investors to move the needle. This really is like a private investment until we have hard facts.
Is there really any selling? There isn't buying either. What did we trade today, $87K worth of stock?
I thought it was very telling during the conference call when after 2 questions, they couldn't get anyone else that wanted to ask a question. It was like a minute to get a caller. Everyone on the line was a private investor. Mainly people on this board. NP shared some very exciting news and the company is clearly on the cusp of some very important milestones, but it was just crickets.
This stock is totally off the radar. Those of us that have been following it for a while and really understand it have loaded up and more exposure probably doesn't make sense. For those with warrants they don't have to buy on the open market as they can take advantage of the TO.
We know institutions can't buy the shares on the OTC and telling this story to private retail investors takes time and is not enough to really move the SP
We are just completely off the grid. I've come to the conclusion that it will take absolute facts to move the SP. I believe those facts are coming, but I don't expect the SP to move until there are hard facts like: TO results, TNBC results, BLA submission, approval, financing deals signed and announced. The SP will not move until we have concrete facts. JMHO
I'm right there with everyone else. A crazy amount of shares, but I feel more comfortable with CYDY than the rest of my diversified portfolio that my money manager put together. The CYDY opportunity of is almost surreal. It really is the investment opportunity of a lifetime. I recognize that anything can happen, but if the worst happened and it went to .00 some day, I would have no regrets. Based on all the facts, I'd do the same thing again.
I ask myself everyday, what am I missing? I'm convinced that the company is just so under the radar. Take the last conference call. There was very positive news on that call. The company is close to big milestones and when the time for questions came, it was crickets. Very few questions, mainly from people on this board. All private investors.
Today there is an abundance of available shares and very few people are even aware of what is happening with this company on the OTC. It's an amazing set of circumstances that has created an incredible opportunity. I've tried to use the wisdom and knowledge I've gained in my years to make the right decision and I stand behind my decision to go all-in on CYDY.
I added a number of additional shares today because:
1. It is very difficult for anyone to dispute that Leronlimab is a very valuable asset. It is worth mutliple times the current CYDY market cap. I haven't heard anyone dispute that.
2. It is hard for me to imagine any scenario where CYDY shareholders don't realize at least some gain from Leronlimab whether through a buyout or through licensing deals. Everything will have to align for it to be a homerun, but a nice double seems very likely.
3. Management continues to overpromise and underdeliver on timelines which has created a lot of frustration and fear in current shareholders and potential investors. I understand this frustration, but the reality is nothing has changed. Leronlimab is still a very valuable asset. There could be more downside but sentiment is very negative right now. Fear and frustration has created a pretty strong buying opportunity. JMHO
This is the exact right take when it comes to CYDY. I hope that CYDY is an amazing home run story but that isn't why I own the stock. This company is significantly undervalued at sub-150 million. Is it worth more than a billion. We will see, but I agree it's worth significantly more than $150 million and that is why I hold a significant position.
This would make sense if there was only one company interested in a licensing deal. That is very unlikely. So yes, CYDY needs the cash but multiple companies are looking to make a deal. The quality of the deal CYDY gets will be driven by the profits CYDY products can provide potential partners not by how badly CYDY needs the cash.
I always like to keep things simple. Here is what we know with certainty based on this morning's volume.
1. Somebody really wants to add a bunch of CYDY shares. That's good.
2. There are a tremendous amount of cheap shares available. That's not as good.
On the whole, somebody is making a meaningful long bet at this price. That is always a good thing. Is there something specific that we don't know about driving this? I tend to think not, but I love seeing this kind of action in CYDY. Means investors see the value here. If we keep getting this kind of action, the cheap shares will go away.
tonysd, you may be right but it would be very odd for them to hold a conference call just to rehash what we already know. At the very minimum they should add significant color to statements they've made in recent press releases.
My post was only a reference to the value of the stock at this moment and whether it should be bought today. I believe the answer to that question is a very strong yes. Was buying the stock for $4 in 2011 a good idea? I wasn't attempting to answer that question.
I'm not saying I would take $3 a share, I'm just saying ask yourself how quickly the company would be sold if offered at $3 a share. If the SP is .51 and any honest observer would admit the company would instantly sell at $3 or maybe a little more today, you accumulate shares. I'd love a 10 bagger, a 16 bagger, etc. but I'm not buying in hopes of a huge homerun. Although that opportunity certainly is real. I'm buying a very promising asset that is seriously on sale.
I don't know how anyone could look at this company and say you should do anything other than buy shares at .51
I wanted to share my newbie perspective to the post below from the individual who questioned if CYDY is doing so well as company, why has the stock dropped from $1.25 to .51. As has been pointed out, the market cap of the company is near it's all time high.
As I accumulate shares, I prefer to focus on the total enterprise value. I understand we will see dilution, that is the cost of doing business. I own a piece of a promising enterprise and I don't have to use my own money to finance it's growth. We can debate that perhaps the financing could be cheaper, but if the company accomplishes its objectives, it's pretty insignifcant.
Here's why I continue to buy shares. I can buy shares for far less than the actual value of the enterprise. If the board put a sign on the front of the building that said, "CYDY For Sale $3 per share", there would be an Under Contract sign on top of it by the end of the business day.
The SP does what it does, but the enterprise gets more valuable each day, I will keep buying shares as long as that is the case.
Since I'm new here, I get the chance to look at things from a very simplistic point of view. We are all confused as to why the SP is so disconnected from the actual value of CYDY. This is how I see it in super simplistic terms.
A stock's price is driven significantly higher when either a large audience of potential investors want to get in on the ride or a small audience of very deep pocketed investors want to do the same.
SP Driver #1(Big Audience): Very few people know about this stock. Unless you had a connection to CYDY you know nothing about it. It's a OTC stock and there is no reason the average investor on the street would know anything about it. I'll use myself as an example, it took my connection nearly 4 years to get me into the stock.
SP Driver #2(Deep Pockets): Until this point, those with deep pockets didn't have to buy common shares. Since the company had to finance its development, they have had the opportunity to take advantage of incredible risk-free investment opportunities. So until this point, deep pockets weren't driving the SP either.
My analysis: Once it is 100% clear the only way to ride the CYDY train is by jumping on board and buying common stock like the rest of us, we will patiently wait. However, once deep pockets start driving the price up quickly, that is when the masses will jump on board and add to the momentum.
That's my novice view of the situation.
Thanks for all the great posts. I'm a CYDY newbie. The person who got me in this stock has been in for about 4 years now. He's been talking to me about PRO140 forever. It usually went in one ear out the other. For some reason I decided to jump in with a small position about 6 weeks ago and have been learning more about the company and the science ever since. The more I learn the more I buy. I have a pretty sizable position and bought a lot more on Friday after the PR. Even this newbie could figure out how positive that PR was. Never seen anything like CYDY. So much upside in what appears to be so little risk.
I'm pretty happy with my current position, but plan to continue to add more as news and events dictate. I kind of feel that this stock is so under the radar that we could get some really good PR and the stock still won't move as much as it should. I don't mind buying more at higher prices if the news provides more certainty.